Shares of Indian pharmaceutical companies slid 2% on Wednesday after U.S. President Donald Trump said he intends to impose ...

Some of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX ... the Doklam impasse in 2017, India chose to become 'aatmanirbhar ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India's pharmaceutical industry is set to grow significantly, with its share in the global market expected to reach 5% by ...